Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Surgeon General Nominee Backs Obama's Positions On Reproductive Health, White House Says
The Washington Post reports that Regina Benjamin -- President Obama"s nominee for U.S. surgeon general -- shares Obama"s position on reproductive health issues, a position that could put her "at odds" with the Catholic Church"s positions on reproductive rights, according to s familiar with her selection. White House spokesperson Reid Cherlin said, "Like [Obama], she believes that this is an issue where it is important to try and seek common ground and come together to try and reduce the number of unintended pregnancies." Cherlin added, "As a physician, she is deeply committed to the philosophy of putting her patients" needs first when it comes to providing care." The White House would not specifically comment on her views on abortion rights, and an HHS spokesperson says Benjamin is not permitted to speak publicly until she is confirmed. s close to Benjamin, who is Catholic, say that she does support abortion rights, the Post reports. However, several individuals who know Benjamin said her views would not affect her role as surgeon general. David Satcher -- a surgeon general in the Clinton administration who taught community health to Benjamin at the Morehouse School of Medicine -- said, "We all have our religions, but when you speak as the surgeon general to the American people, it"s not about your religion." He added, "I don"t see why the surgeon general has to get involved in a discussion about abortion." Jorge Alsip -- president of the Medical Association of the State of Alabama -- said abortion-related issues occasionally arose when he and Benjamin served on the Alabama State Committee on Public Health. Alsip, who is Catholic, said he does not know her position on the issue, adding, "You kind of have to park your personal beliefs at the door when they conflict with what your role is."Sister Carol Keehan, president and CEO of the Catholic Health Association, said, "This is not pivotal to the surgeon general"s job." She added, "From the perspective of being a practicing Catholic, you can certainly say that it matters. I think being willing to work to reduce (abortion) is a good thing."Robert Lawrence, a director at Johns Hopkins University"s Bloomberg School of Public Health and chair of the board of Physicians for Human Rights, served with Benjamin on the group"s board from 1996 until 2002. He said, "I would think that as surgeon general she would uphold the law of the land, and the law of the land guarantees women a choice for reproductive health." He added, "The charge of the surgeon general is to be the people"s doctor and ensure that all those health services guaranteed under federal law are available to the people" (Thompson, Washington Post, 7/19).
generic viagra online
Organic Food No Better Nutritionally Than Conventionally Produced, Research Review
Scientists in the UK who systematically reviewed research from the last 50 years concluded that from a nutritional point of view, organically
plastic surgery before after
News of the day
New Electrodes May Help Amputees And Paralyzed Control Bionic Limbs
Experimental devices that read brain signals have helped paralyzed people use computers and may let amputees control bionic limbs. But existing devices use tiny electrodes that poke into the brain. Now, a University of Utah study shows that brain signals controlling arm movements can be detected accurately using new microelectrodes that sit on the brain but don"t penetrate it.
Nutrition

Mylan Again Calls For An End To Authorized Generics During 180-Day Exclusivity Period

Mylan Inc."s (NASDAQ: MYL) Chief Operating Officer Heather Bresch today testified before the U.S. House of Representatives Judiciary Subcommittee on Courts and Competition Policy concerning patent litigation settlements between branded pharmaceutical companies and generic pharmaceutical companies. During her testimony, Bresch conveyed Mylan"s position that the launch of an authorized generic by brand companies during a generic company"s 180-day exclusivity period undermines competition and delays timely access to high quality, affordable generic medications for patients, taxpayers, the government and businesses. The committee"s hearing, "Pay to Delay: Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive?," was called to gather information about the effects of settlements. Bresch commented: "When it comes to settlements, Congress need look no further than the use and abuse of authorized generics by brand manufacturers. The increase in the number of patent litigation settlements in recent years is directly related to the increased use of authorized generics during the 180-day market exclusivity period. This tactic upsets the natural balance of incentives that Congress intended with its 1984 Hatch-Waxman legislation." Bresch continued: "Congress has an opportunity to act now to ensure that timely access to affordable generics is offered to patients by restoring the true 180-day exclusivity period. This is even more profound and critical today as Congress deliberates on a regulatory pathway for life-saving generic biologics, treatments that can cost hundreds of thousands of dollars per patient per year." A complete version of Bresch"s written testimony for the subcommittee hearing can be found here. Mylan Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009